Immediate Impact
1 from Science/Nature 61 standout
Citing Papers
Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
Thyroid Cancer
2024 Standout
Works of D. Otto being referenced
Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer
2004
Influence of rhTSH on [18F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma
2002
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| D. Otto | 81 | 142 | 68 | 154 | 109 | 17 | 457 | |
| S-L Wang | 35 | 171 | 31 | 44 | 91 | 23 | 487 | |
| Rodolfo Nasti | 52 | 113 | 19 | 57 | 100 | 13 | 417 | |
| Zhenfeng Zheng | 66 | 82 | 18 | 56 | 70 | 31 | 506 | |
| Chris P. H. Lexis | 47 | 112 | 49 | 104 | 169 | 27 | 508 | |
| Ting‐Ting Wu | 52 | 107 | 72 | 38 | 62 | 18 | 386 | |
| Valentina Angelini | 55 | 205 | 34 | 100 | 40 | 14 | 500 | |
| P J Wood | 21 | 154 | 25 | 36 | 80 | 24 | 473 | |
| Chufan Luo | 48 | 24 | 25 | 101 | 104 | 28 | 384 | |
| Simone Gschwend | 45 | 61 | 27 | 86 | 48 | 16 | 441 | |
| Holger Leitolf | 58 | 74 | 24 | 31 | 63 | 20 | 384 |
All Works
Loading papers...